Stereotactic body radiation therapy for the treatment of oligoprogression on androgen receptor targeted therapy in castration-resistant prostate cancer

Castration-resistant prostate cancer is an incurable disease. To date, six agents-abiraterone, enzalutamide, docetaxel, cabazitaxel, radium-223 and sipuleucel-T- have shown clinical efficacy in phase III clinical trials, leading to their FDA approval. Patients are typically sequenced through most or...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thu-Cuc, Bajwa, Ravneet, Bari, Shahla, Ali, Azka, Paul Skelton, William, Federico, Roland-Austin, Bishnoi, Rohit, Wray, Justin W, Zlotecki, Robert A, Dang, Long H, Muzaffar, Jameel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761507/
https://www.ncbi.nlm.nih.gov/pubmed/29340160
http://dx.doi.org/10.1093/omcr/omx078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761507/
https://www.ncbi.nlm.nih.gov/pubmed/29340160
http://dx.doi.org/10.1093/omcr/omx078

Ejemplares similares